Emcure Pharmaceuticals Ltd. (EMCURE): Emcure Pharmaceuticals Share Price rises 2.04% to Rs 1,896.05

Emcure Pharmaceuticals Share Price is trading at Rs 1,896.05, up 2.04% from the previous close of Rs 1,858.10, with market capitalisation at Rs 35,234.74 crore as of 04 September 2026 at 9:35:19 AM IST. The move places Emcure Pharmaceuticals Ltd. in focus in today’s stock news, even though the latest Univest data confirms the price event but does not establish a company-specific catalyst.

For readers tracking Emcure Pharmaceuticals Share Price Today, the near-term setup is driven by price action, valuation and sector positioning rather than any verified trigger. The stock opened at Rs 1,889.00, touched a high of Rs 1,899.00 and a low of Rs 1,876.00, while turnover stood at Rs 0.53 crore. In this Emcure Pharmaceuticals Stock News note, Univest looks at what the move means in the context of the company’s financial ratios, the Healthcare sector and peer comparison. Investors watching Emcure Pharmaceuticals Share Price can use today’s move as a starting point for stock analysis, fundamental analysis and market-cap context, while checking whether the rally remains aligned with broader Indian stock market trends.

Emcure Pharmaceuticals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,896.05
Previous Close	Rs 1,858.1
Today's Move	Rs 37.95 (+2.04%)
Open	Rs 1,889
High	Rs 1,899
Low	Rs 1,876
Turnover	Rs 0.53 crore
Market Capitalisation	Rs 35,234.74 crore
Market Cap Category	Large Cap

Emcure Pharmaceuticals Ltd. (EMCURE) rose to Rs 1,896.05 from the previous close of Rs 1,858.1, a move of Rs 37.95 or 2.04%. The stock opened at Rs 1,889, reached a high of Rs 1,899, recorded a low of Rs 1,876.

Emcure Pharmaceuticals Share Price Today reflects a Rs 37.95 gain from the previous close, with the stock last traded at Rs 1,896.05 after moving between Rs 1,876.00 and Rs 1,899.00 in the current market update. The latest Univest figures show a 2.04% rise, and the stock’s position within that intraday band suggests active interest in Emcure Pharmaceuticals Stock News without any verified company-specific catalyst. For readers scanning Stocks in News or Top Gainers Today, the main takeaway is straightforward: Emcure Pharmaceuticals Share Price is higher today, and the move is factual rather than narrative-driven. Univest tracks such price action because it often becomes the first signal investors use before moving into deeper fundamental analysis.

Emcure Pharmaceuticals Ltd. (EMCURE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 35,234.74 crore
P/E Ratio	34.85x
P/B Ratio	6.74x
ROE	20.09%
ROCE	25.25%
EPS	Rs 53.32
Book Value Per Share	Rs 275.73
Dividend Yield	0.19%

Emcure Pharmaceuticals Ltd. (EMCURE) fundamental metrics show P/E 34.85x, P/B 6.74x, ROE 20.09%, ROCE 25.25%. These figures provide context only and are not a buy or sell signal.

Emcure Pharmaceuticals Ltd. has a market capitalisation of Rs 35234.74 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 34.85x, P/B at 6.74x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.09% and ROCE of 25.25%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 53.32, book value per share of Rs 275.73, dividend yield of 0.19%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.61x, median ROE of 11.79%, median ROCE of 13.66%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	34.85x
Benchmark Median P/E	32.61x
Benchmark Average P/E	48.83x
Benchmark P/E Range	3.32x to 645.91x
Company P/B Ratio	6.74x
Benchmark Median P/B	2.89x
Company ROE	20.09%
Benchmark Median ROE	11.79%
Company ROCE	25.25%
Benchmark Median ROCE	13.66%
Company Market Capitalisation	Rs 35,234.74 crore
Benchmark Median Market Cap	Rs 730.27 crore

Emcure Pharmaceuticals Ltd. (EMCURE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Emcure Pharmaceuticals Ltd. (EMCURE) has a P/E ratio of 34.85x, which is above the benchmark median of 32.61x, a difference of +6.87%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Emcure Pharmaceuticals Ltd. (EMCURE) has a ROE of 20.09%, which is above the benchmark median of 11.79%, a difference of +70.4%. Emcure Pharmaceuticals Ltd. (EMCURE) has a ROCE of 25.25%, which is above the benchmark median of 13.66%, a difference of +84.85%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,63,791.45	37.77	5.28	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,45,080.59	83.91	13.89	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,90,351.29	85.89	20.87	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,14,832.64	25.09	4.2	19.69	21.39
Cipla Ltd.	CIPLA	1,14,162.52	33.29	3.19	11.83	16

Emcure Pharmaceuticals Ltd. (EMCURE) has a P/E ratio of 34.85x compared with the displayed peer median of 37.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.09% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 25.25% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Emcure Pharmaceuticals Ltd. (EMCURE) has a market capitalisation of Rs 35,234.74 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Emcure Pharmaceuticals

• Emcure Pharmaceuticals Share Price is trading higher today, and the 2.04% rise has placed the stock in focus among Stocks Rising Today.
• The current price of Rs 1,896.05 sits above the previous close of Rs 1,858.10, making the day’s price action easy to track in market news.
• Market capitalisation of Rs 35,234.74 crore gives the company meaningful scale within Healthcare and Pharmaceuticals & Drugs.
• P/E, P/B, ROE and ROCE provide a useful fundamental context for Emcure Pharmaceuticals Stock Analysis.
• Peer comparison shows the stock is priced below some higher-multiple pharma names but above several lower-multiple peers.

About Emcure Pharmaceuticals

Emcure Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company focuses on pharmaceutical products, which typically include prescription medicines and related healthcare offerings across different therapeutic areas. For investors reading Emcure Pharmaceuticals Company News or Emcure Pharmaceuticals Latest News, the key point is that the business sits inside a competitive Indian pharma landscape where valuation, returns and scale often matter as much as near-term price movement.

Emcure Pharmaceuticals Share Price becomes relevant because the company’s reported size, return ratios and earnings per share place it among the more closely watched names in the industry. With a market capitalisation of Rs 35,234.74 crore, EPS of Rs 53.32 and ROCE of 25.25%, the company has enough financial presence to attract attention during stock market today moves. Univest tracks such names because understanding the company overview helps readers interpret whether a daily share price rise is occurring alongside a stronger business profile.

Frequently Asked Questions

Why is Emcure Pharmaceuticals Share Price rising today?

What is Emcure Pharmaceuticals Share Price today?

Ans. Emcure Pharmaceuticals Share Price Today is Rs 1,896.05, higher than the previous close of Rs 1,858.10. The move adds Rs 37.95 during the current market update. The stock moved 2.04% so far today.

What is the market capitalisation of Emcure Pharmaceuticals?

Ans. Emcure Pharmaceuticals Market Cap stands at Rs 35,234.74 crore. That places the company well above the same-industry median and average, indicating meaningful scale within Healthcare. The company operates in the Healthcare sector.

How does Emcure Pharmaceuticals look on valuation?

Ans. Emcure Pharmaceuticals trades at a P/E of 34.85 and a P/B of 6.74. Both are above the industry medians, so the stock is priced at a premium to many peers.

What do ROE and ROCE show for Emcure Pharmaceuticals?

Ans. ROE is 20.09% and ROCE is 25.25%. Both are above the same-industry median, which supports the company’s return profile in fundamental analysis. The relevant peer median ROE is 11.79%.

What do EPS and book value mean for Emcure Pharmaceuticals Share Price?

Ans. EPS is Rs 53.32 and book value is Rs 275.73. EPS reflects earnings per share, while book value shows accounting net worth behind each share. The previous close was Rs 1,858.1.

How does Emcure Pharmaceuticals compare with pharma peers?

Ans. Emcure Pharmaceuticals is smaller than Sun Pharma, Divi’s and Torrent by market cap, but its ROE and ROCE compare well. Its valuation is also below some richer-rated pharma peers.

Should investors track Emcure Pharmaceuticals Share Price on Univest?

Ans. Yes. Univest helps track Emcure Pharmaceuticals Share Price, market cap, valuation ratios and peer context in one place, which is useful when the stock is rising and attracting market attention.

Track Emcure Pharmaceuticals Share Price on Univest

Use Emcure Pharmaceuticals Ltd. (EMCURE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track Emcure Pharmaceuticals Share Price on Univest for live price updates, market capitalisation, valuation ratios, company financials and sector comparison. Univest also helps readers monitor Emcure Pharmaceuticals Share Price Today alongside key fundamentals, broader market news and relative peer positioning, making it easier to follow the stock without chasing short-term noise.

Image ALT: Emcure Pharmaceuticals Share Price rises 2.04% to Rs 1,896.05 with market cap and valuation context on Univest.